PLSM

Pulsenmore Ltd

Jun 24 • 10:49AM ET

9.96

+6.55 192.09 %

Healthcare • Medical Devices • Israel • Micro • NASD

Today, 7:05 AMPulsenmore partners with Ouma Health to integrate FDA-authorized home ultrasound platform into Ouma’s U.S. virtual maternity care services

Peers: MODD NVNO IRIX ICCM VNRX TRIB VTAK TNON BMRA CTSO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.66	Insider Own	40.65%	Shs Outstand	6.50M	Perf Week	158.70%
Market Cap	64.74M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.86M	Perf Month	121.83%
Enterprise Value	43.49M	PEG	-	EPS next Q	-	Inst Own	8.42%	Short Float	0.07%	Perf Quarter	149.63%
Income	-4.23M	P/S	5.40	EPS this Y	-	Inst Trans	4.73%	Short Ratio	0.14	Perf Half Y	-
Sales	12.00M	P/B	2.48	EPS next Y	-	ROA	-11.94%	Short Interest	0.00M	Perf YTD	35.33%
Book/sh	4.01	P/C	2.98	EPS next 5Y	-	ROE	-16.07%	52W High	10.28 -3.11%	Perf Year	-
Cash/sh	3.34	P/FCF	-	EPS past 3/5Y	13.21% -1.94%	ROIC	-16.13%	52W Low	3.00 231.99%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.32% -	Gross Margin	84.54%	Volatility	7.80% 5.95%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.62	EPS Y/Y TTM	58.17%	Oper. Margin	-26.48%	ATR (14)	0.99	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.22	Sales Y/Y TTM	360.00%	Profit Margin	-35.26%	RSI (14)	85.94	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	7.88	EPS Q/Q	137.89%	SMA20	125.16%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.02	Sales Q/Q	660.33%	SMA50	146.34%	Rel Volume	8546.09	Prev Close	3.41
Employees	63	LT Debt/Eq	0.01	Earnings	Mar 30 BMO	SMA200	123.78%	Avg Volume	19.07K	Price	9.96
IPO	Jan 21, 2026	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	39,512,712	Change	192.09%

Today 07:00AM	Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States (PR Newswire) +192.09%
Mar-30-26 08:29AM	Pulsenmore Announces Full Year 2025 Financial Results and Webcast (PR Newswire)
Mar-25-26 08:00AM	Pulsenmore Announces Full Year 2025 Earnings Conference Call (PR Newswire) -5.51%
Feb-09-26 07:00AM	Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance (PR Newswire)
Feb-02-26 07:13AM	Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center (PR Newswire)
07:30AM	Loading…
Jan-26-26 07:30AM	Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation (PR Newswire)
Jan-23-26 10:06AM	Pulsenmore to commence trading on Nasdaq (TipRanks)
Jan-21-26 07:30AM	Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S. (PR Newswire)

Pulsenmore Ltd. engages in research and development, production, marketing, and sale of self-scan ultrasound devices for remote clinical diagnosis and screening. It also offers a mobile app that guides the patient through a self-scan and enables online consolation with a clinician; as well as a clinician dashboard that allows clinicians to review scans and interacts with the patient remotely. The company was founded by Elazar Sonnenschein on October 27, 2014 and is headquartered in Omer, Israel.

FounderDr. Elazar Sonnenschein

Chief Financial OfficerMr. Eran Hirsh

Vice President of R&DMr. Minelu Sonnenschein

Vice President of Software DevelopmentMr. Meir Shmouely

General Counsel & Company SecretaryMr. Michael Hamelsdorf

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PLSM

Pulsenmore Ltd

Upgrade your Finviz experience